The quality of antimalarial medicines in western cambodia: A case study along the thai-cambodian border

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 44, Issue 3, 2013, Pages 349-362

  Phanouvong, Souly ^a   Raymond, Christopher ^b   Krech, Laura ^c   Dijiba, Yanga ^a   Mam, Boravann ^d   Lukulay, Patrick ^a   Socheat, Duong ^d   Sovannarith, Tey ^e   Sokhan, Chroeng ^f  

^a UNITED STATES PHARMACOPEIA   (United States)

^b United States Pharmacopeia   (Indonesia)

^c United States Pharmacopeia   (United States)

^d Parasitology and Entomology   (United States)

^e National Health Product Quality Control Laboratory   (United States)

^f Ministry of Health Cambodia   (Cambodia)

Author keywords

Active pharmaceutical ingredient; Antimalarial medicine; Availability; Quality; Western cambodia

Indexed keywords

EID: 84882699770     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Denis MB, Tsuyuoka R, Poravuth Y, et al. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health 2006; 11: 1360-6.
2. Dondorp A, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361:455-67.
3. Dondorp A, Yeung S, White L, et al. Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol 2010; 8: 272-80.
4. Global Pharma Health Fund (GPHF). E.V. The GPHF-Minilab®- Protection against coun-terfeit medicines. Frankfurt: GPHF, 2011. Cited on 2011 Dec 7, Available from: URL: http://www.gphf.org/web/en/minilab.
5. Lon CT, Tsuyuoka R, Phanouvong S, et al. Counterfeit and substandard anti-malarial drugs in Cambodia. Trans R Soc Trop Med Hyg 2006; 100:1019-24.
6. Ministry of Health (MOH) Cambodia. Study report on counterfeit and substandard drugs in Cambodia. Phnom Penh: MOH Cambodia, 2001.
7. Newton PN, Fernandez FM, Planqon A, et al. A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia. PLoS Med 2008; 5(2): e32.
8. PATH. Piloting a malaria public-private mix model in Cambodia. Washington, DC: Center for Health Market Innovation, 2011. Cited 2012 Jun 13. Available from: URL: http://healthmarketinnovations.org/sites/ healthmarketinnovations.org/files/CP-cambodia-malaria-ppm-Cambodia.pdf.
9. Phanouvong S, Jahnke RO, Morse N. Using simple techniques to detect poor-quality ARVs. Poster presentation at the Seventh International Congress on AIDS in Asia and the Pacific, 2005.
10. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science 2004; 305(5687): 1124.
11. Thimasarn K, Sirichaisinthop J, Vijaykadga S, et al. In vivo study of the response of Plasmodium falciparum to standard meflo- quine/sulfadoxine/ pyrimethamine (MSP) treatment among gem miners returning from Cambodia. Southeast Asian TropMed Public Health 1995; 26: 204-12.
12. United States Pharmacopeia (USP). Promoting the quality of medicines program strength-ening national capacity in medicines quality: five-year summary (2005-2009). Rockville, MA: USP, 2010a.
13. United States Pharmacopeia (USP). Cambodia takes action in fight against substandard and counterfeit medicines as unprecedented number of illegal pharmacies are forced to shut down. Rockville, MA: USP, 2010b. Cited 2012 Jun 13. Available from: URL: http://us.vocuspr.com/Newsroom/ViewAttachment.aspx? SiteName=USPharm&Entity=PRA-sset&AttachmentType=F&EntityID= 108241&AttachmentID=ff348a33-96eb-4da2-bdlc-6fb796f2fb88.
14. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wong- srichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health 2006; 11: 211-9.
15. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug- resistant malaria. Lancet Infect Dis 2002; 2: 209-18.
16. World Health Organization (WHO). Susceptibility of Plasmodium falciparum to antimalarial drugs: Report on global monitoring 1996-2004; WHO,/HTM/MALI2005.1103, 2005. Cited 2011 Dec 7, Available from: URL: http://whqlibdoc.who.int/publica-tions/2005/9241593466eng.pdf.
17. World Health Organization (WHO). Containment of malaria multi-drug resistance on the Cambodia-Thailand border: Report of an informal consultation. Phnom Penh: WHO, 29-30 January 2007. Cited 2011 Dec 9. Available from: URL: http://www.who.int/malaria/publications/atoz/multidrug.resistance/en/.
18. World Health Organization (WHO). Global report on antimalarial efficacy and drug resistance: 2000-2010. Geneva: WHO, 2010a. Cited 2011 Dec 9. Available from: URL: http://www.who.int/malaria/publications/atoz/9789241500470/en/.
19. World Health Organization (WHO). Guidelines for the treatment of malaria. 2nd ed. Geneva: WHO, 2010b. Cited 2011 Dec 9, Available from: URL: http://whqlibdoc.who.int/publications/2010/9789241547925-eng.pdf.
20. World Health Organization (WHO). Battling malaria drug resistance along the Thai- Cambodian border. Geneva: WHO, 2011a. Cited 2011 Dec 7, Available from: URL: http://www.who.int/malaria/diagno-sistreatment/arcp/ containmentproject/en/index.html.
21. World Health Organization (WHO). Medicines: General information on counterfeit medicines. Geneva: WHO, 2011b. Cited 2011 Dec 7. Available from: URL: http://www.who.int/medicines/services/counterfeit/overview/en/.
22. Yamane T. Statistics: An introductory analysis. 2nd ed. New York: Harper and Row, 1967.